Analysis of admissions with bronchial asthma and chronic obstructive pulmonary disease exacerbations

Cover Page


Cite item

Full Text

Abstract

Aim. To study the factors worsening the course of chronic obstructive pulmonary disease and bronchial asthma.

Methods. At the first stage, assessment of 1561 case histories of patients with internal diseases was performed, of whom 341 had lung diseases. A more detailed analysis with the assessment of the clinical characteristics of hospitalized patients was conducted at the second stage of our study, which included evaluation of 38 case histories of patients over a 6-month period in 2016.

Results. In the structure of mortality from lung disease chronic obstructive pulmonary disease is the dominant cause (53.8%) predominating deaths from pneumonia (46.2%). Mean age of patients who died from chronic obstructive pulmonary disease was 67.2±5.97 years. Exacerbation of chronic obstructive pulmonary disease was the cause of hospitalization in 24 (63.2%) cases, bronchial asthma in 11 (28.9%) cases, chronic obstructive pulmonary disease and asthma overlap syndrome was observed in 3 (7.9%) cases. Exacerbation of chronic bronchoobstructive pathology was mostly caused by respiratory tract infections (84.2% of cases), which required administration of pluripotent antibacterial therapy. In 60.5% cases deterioration of concomitant diseases was observed with cardiovascular diseases prevailing (arterial hypertension, chronic heart failure decompensation).

Conclusion. When organizing the strategy of urgent care for patients with chronic bronchoobstructive diseases, paying more attention to assessment of comorbidities is relevant; it is critical to raise awareness of practicing physicians of the criteria for the diagnosis of asthma and chronic obstructive pulmonary disease overlap syndrome.

About the authors

L Yu Pal’mova

Kazan State Medical University

Author for correspondence.
Email: palmova@bk.ru

A A Podol’skaya

Kazan State Medical University; City clinical hospital №7

Email: palmova@bk.ru

Z A Shaykhutdinova

City clinical hospital №7

Email: palmova@bk.ru

D A Zaplatova

City clinical hospital №7

Email: palmova@bk.ru

E B Druzhkova

Kazan State Medical University

Email: palmova@bk.ru

References

  1. Авдеев С.Н. Хроническая обструктивная болезнь лёгких: обострения. Пульмонология. 2013; (3): 5-15.
  2. Алексеенко С.Н., Дробот Е.В. Профилактика заболеваний. Научная электронная библиотека. http://www.monographies.ru/en/book/section?id=9641 (дата обращения: 15.09.2016).
  3. Белевский А.С. Синдром перекрёста бронхиальной астмы и хронической обструктивной болезни лёгких (по материалам совместного документа рабочих групп экспертов GINA и GOLD). Атмосфера. Пульмонол. и аллергол. 2014; (2): 1-8.
  4. Визель А.А., Визель И.Ю., Амиров Н.Б. Хроническая обструктивная болезнь лёгких (ХОБЛ). Перемены как повод для обсуждения. Вестн. соврем. клин. мед. 2015; 8 (1): 62-69.
  5. Ненашева Н.М. GINA 2014: обзор некоторых основных изменений. Практ. пульмонол. 2014; (3): 2-14.
  6. Федеральные клинические рекомендации по диагностике и лечению бронхиальной астмы. Под ред. А.Г. Чучалина. 2016; 55.
  7. Чучалин А.Г., Авдеев С.Н., Айсанов З.Р. и др. Федеральные клинические рекомендации по диагностике и лечению хронической обструктивной болезни лёгких. Пульмонология. 2014; (3): 15-54.
  8. Vogelmeier C., Vestbo J. COPD assessment: I, II, III, IV and/or A, B, C, D. Eur. Respir. J. 2014; 43 (4): 949-950. http://dx.doi.org/10.1183/09031936.00019714
  9. Weatherall M., Travers J., Shirtcliffe P.M. et al. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur. Respir. J. 2009; 34: 812-818. http://dx.doi.org/10.1183/09031936.00174408

Supplementary files

Supplementary Files
Action
1. JATS XML

© 2016 Pal’mova L.Y., Podol’skaya A.A., Shaykhutdinova Z.A., Zaplatova D.A., Druzhkova E.B.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.





This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies